EMA — authorised 12 November 1998
- Marketing authorisation holder: KRKA, D.D., NOVO MESTO
- Status: approved
EMA authorised Micardis on 12 November 1998
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 12 November 1998.
KRKA, D.D., NOVO MESTO holds the EU marketing authorisation.